Drug Type in vivo CAR-T therapy |
Synonyms STR P004, STRP004 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD19 positive Non-Hodgkin Lymphoma | Phase 1 | China | 01 Jun 2025 | |
Autoimmune Diseases | Preclinical | China | 01 May 2025 |